Inotrem S.A.’s €39 Million Series B Financing Round

Paolo Bossi

Goodwin and Jones Day advised on the deal Jones Day advised Inotrem S.A., a French biotech company specialized in immunotherapy for acute and chronic inflammatory syndromes,…

This content is for Standard 1 Year members only.
Login Join Now
Avatar

Author: Paolo Bossi

…

This content is for Standard 1 Year members only.
Login Join Now